Drug Shortage Report for FLUMIST QUADRIVALENT

Last updated on 2020-09-24 History
Report ID 82164
Drug Identification Number 02426544
Brand name FLUMIST QUADRIVALENT
Common or Proper name Influenza vaccine (live, attenuated)
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) Influenza Virus Type A Influenza Virus Type A Influenza virus type B Influenza virus type B
Strength(s) 32000000FFU 32000000FFU 32000000FFU 32000000FFU
Dosage form(s) SPRAY
Route of administration NASAL
Packaging size 10 single use pre-filled syringes
ATC code J07BB
ATC description VIRAL VACCINES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2019-10-01
Actual start date 2019-10-01
Estimated end date 2020-09-23
Actual end date 2020-09-23
Shortage status Resolved
Updated date 2020-09-24
Company comments Influenza vaccine for 2020-2021 season estimated availability September 23, 2020, in limited quantities
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-09-24 French Compare
v17 2020-09-24 English Compare
v16 2020-09-22 French Compare
v15 2020-09-22 English Compare
v14 2020-09-18 French Compare
v13 2020-09-18 English Compare
v12 2020-09-10 French Compare
v11 2020-09-10 English Compare
v10 2020-07-16 French Compare
v9 2020-07-16 English Compare
v8 2019-10-02 English Compare
v7 2019-10-01 French Compare
v6 2019-10-01 English Compare
v5 2019-04-22 French Compare
v4 2019-04-22 English Compare
v3 2019-04-22 French Compare
v2 2019-04-22 English Compare
v1 2019-04-22 English Compare

Showing 1 to 18 of 18